Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25980773 | 0.88 | MERTK (0.40) | ALDH1A1HPGDKCNH2KMT2ASMN1; SMN2 | |
| SCHEMBL25980785 | 0.86 | HDAC1 (0.40) | ALDH1A1HPGDKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL25980762 | 0.86 | HDAC1 (0.39) | ALDH1A1HPGDKCNH2KMT2ASMN1; SMN2 | |
| SCHEMBL25980814 | 0.85 | ALDH1A1 (0.40) | ALDH1A1KCNH2KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL25980818 | 0.85 | SMN1; SMN2 (0.38) | L3MBTL1ALDH1A1HPGDKCNH2KMT2A | |
| SCHEMBL25980920 | 0.82 | L3MBTL1 (0.42) | L3MBTL1CYP1A2CYP3A4CYP2C9ALDH1A1 | |
| SCHEMBL25981153 | 0.81 | CCR5 (0.41) | L3MBTL1CYP1A2CYP3A4CYP2C9ALDH1A1 | |
| SCHEMBL25980754 | 0.81 | HDAC6 (0.48) | ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL25979308 | 0.78 | TSHR (0.41) | L3MBTL1ALDH1A1HPGDKMT2AMEN1 | |
| SCHEMBL25981775 | 0.76 | HPGD (0.47) | ALDH1A1HPGDKMT2AMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248735-A1 | COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248735-A1 | COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) | NR1H2, CFTR, CYP11B2 | L3MBTL1 4497/4885CYP1A2 432/4885CYP3A4 1676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.